The treatment of Stanford type B aortic dissection with unhealthy or short anchoring zone using physician-modified fenestration TEVAR
10.3760/cma.j.cn113855-20200119-00038
- VernacularTitle:体外预开窗腔内修复治疗非健康锚定区及短锚定区B型主动脉夹层的前瞻性单中心研究
- Author:
Fanguo HU
1
;
Jiechang ZHU
;
Xiangchen DAI
;
Yudong LUO
;
Hailun FAN
;
Zhou FENG
;
Yiwei ZHANG
Author Information
1. 天津医科大学总医院血管外科 300052
- From:
Chinese Journal of General Surgery
2020;35(7):536-539
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the efficacy and safety of physician-modified fenestration TEVAR for treating type B aortic dissection with unhealthy or short anchoring zone.Methods:Clinical data of patients with type B aortic dissection who received TEVAR for left subclavian artery fenesration from May 2016 to Dec 2018 were analyzed prospectively.Results:The technical success rate was 93.2%. One case was converted into chimney stenting. One case suffered type Ⅰendoleak. One case had type Ⅲ endoleak. There were no deaths or neurological complications during the perioperative period, and the mean hospital stay was 9.2 (5-26) days. The median follow-up time was 30 (12-42) months. One case developed type Ⅰ endoleak during follow-up. No retrograde dissection occurred and all LSA stents remained patent.Conclusion:Physician-modified fenestration TEVAR is safe and effective for the treatment of type B aortic dissection with unhealthy or short anchoring zone.
